These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy. Masuda S; Tamura K; Wakui H; Maeda A; Dejima T; Hirose T; Toyoda M; Azuma K; Ohsawa M; Kanaoka T; Yanagi M; Yoshida S; Mitsuhashi H; Matsuda M; Ishigami T; Toya Y; Suzuki D; Nagashima Y; Umemura S Am J Physiol Renal Physiol; 2010 Oct; 299(4):F720-31. PubMed ID: 20685825 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain. Taguchi S; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Hirota K; Tsukamoto S; Morita R; Kobayashi R; Kinguchi S; Yamashita A; Wakui H; Tamura K Hypertens Res; 2024 Jan; 47(1):55-66. PubMed ID: 37957242 [TBL] [Abstract][Full Text] [Related]
9. The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019. Wakui H Clin Exp Nephrol; 2020 Apr; 24(4):289-294. PubMed ID: 32112267 [TBL] [Abstract][Full Text] [Related]
10. Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension. Ohsawa M; Tamura K; Wakui H; Maeda A; Dejima T; Kanaoka T; Azushima K; Uneda K; Tsurumi-Ikeya Y; Kobayashi R; Matsuda M; Uchida S; Toya Y; Kobori H; Nishiyama A; Yamashita A; Ishikawa Y; Umemura S Kidney Int; 2014 Sep; 86(3):570-81. PubMed ID: 24694992 [TBL] [Abstract][Full Text] [Related]
12. ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond. Tamura K; Azushima K; Kinguchi S; Wakui H; Yamaji T Hypertens Res; 2022 Jan; 45(1):32-39. PubMed ID: 34642449 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization. Abe E; Yamashita A; Hirota K; Yamaji T; Azushima K; Urate S; Suzuki T; Tanaka S; Taguchi S; Tsukamoto S; Uehara T; Wakui H; Tamura K; Takahashi H Sci Rep; 2022 Oct; 12(1):17376. PubMed ID: 36253401 [TBL] [Abstract][Full Text] [Related]
14. miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap. Hirota K; Yamashita A; Abe E; Yamaji T; Azushima K; Tanaka S; Taguchi S; Tsukamoto S; Wakui H; Tamura K J Biol Chem; 2023 Dec; 299(12):105478. PubMed ID: 37981211 [TBL] [Abstract][Full Text] [Related]
15. Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension. Kinguchi S; Wakui H; Azushima K; Haruhara K; Koguchi T; Ohki K; Uneda K; Matsuda M; Haku S; Yamaji T; Yamada T; Kobayashi R; Minegishi S; Ishigami T; Yamashita A; Fujikawa T; Tamura K J Am Heart Assoc; 2019 Apr; 8(8):e012395. PubMed ID: 30977419 [TBL] [Abstract][Full Text] [Related]
16. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624 [TBL] [Abstract][Full Text] [Related]
17. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Azuma K; Tamura K; Shigenaga A; Wakui H; Masuda S; Tsurumi-Ikeya Y; Tanaka Y; Sakai M; Matsuda M; Hashimoto T; Ishigami T; Lopez-Ilasaca M; Umemura S Hypertension; 2007 Nov; 50(5):926-32. PubMed ID: 17875818 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin receptor-binding molecule in leukocytes in association with the systemic and leukocyte inflammatory profile. Haruhara K; Wakui H; Azushima K; Kurotaki D; Kawase W; Uneda K; Haku S; Kobayashi R; Ohki K; Kinguchi S; Ohsawa M; Minegishi S; Ishigami T; Matsuda M; Yamashita A; Nakajima H; Tamura T; Tsuboi N; Yokoo T; Tamura K Atherosclerosis; 2018 Feb; 269():236-244. PubMed ID: 29407599 [TBL] [Abstract][Full Text] [Related]
20. Ablation of Immunoproteasome β5i Subunit Suppresses Hypertensive Retinopathy by Blocking ATRAP Degradation in Mice. Wang S; Li J; Wang T; Bai J; Zhang YL; Lin QY; Li JM; Zhao Q; Guo SB; Li HH Mol Ther; 2020 Jan; 28(1):279-292. PubMed ID: 31636038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]